Related Experiment Video

Updated: May 3, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K

The role of KIR2DS1 in multiple sclerosis--KIR in Portuguese MS patients

Andreia Bettencourt1, Ana Martins Silva2, Cláudia Carvalho1

  • 1UMIB - Instituto de Ciências Biomédicas Abel Salazar (ICBAS-UPorto), Porto Portugal.

Journal of Neuroimmunology
|February 18, 2014
PubMed

Insights

Killer Immunoglobulin-like Receptor (KIR) genes, specifically KIR2DS1, appear to protect against Multiple Sclerosis (MS). This activating KIR gene may influence MS susceptibility by modulating autoreactive T cells via Natural Killer cells.

Area of Science:

  • Immunogenetics
  • Autoimmune Diseases
  • Neuroimmunology

Background:

  • Killer Immunoglobulin-like Receptor (KIR) genes' role in autoimmune diseases is known, but their specific involvement in Multiple Sclerosis (MS) pathogenesis remains unclear.
  • Investigating genetic factors influencing MS susceptibility is crucial for understanding disease mechanisms.

Purpose of the Study:

  • To investigate the influence of KIR genes on Multiple Sclerosis (MS) susceptibility in a Portuguese cohort.
  • To explore potential genetic interactions between KIR genes and their HLA class I ligands in MS pathogenesis.

Main Methods:

  • Analysis of KIR gene polymorphisms in 447 Portuguese MS patients.
  • Statistical analysis to determine associations between KIR genes, HLA class I ligands, and MS susceptibility.
  • Assessing the independent effect of KIR2DS1 and HLA-DRB1*15 alleles.

Main Results:

  • A significant negative association was observed between the activating KIR2DS1 gene and MS susceptibility (adjusted OR=0.450, p=0.030).
  • This protective effect of KIR2DS1 was independent of the presence of the HLA-DRB1*15 allele.
  • The findings suggest a potential role for Natural Killer (NK) cell modulation of autoreactive T cells.

Conclusions:

  • The activating KIR2DS1 gene may confer protection against Multiple Sclerosis.
  • KIR2DS1's influence on MS susceptibility might involve the modulation of autoreactive T cells by Natural Killer cells.
  • Further research into KIR-HLA interactions is warranted for understanding MS immunopathogenesis.
Keywords:
KIRMultiple SclerosisNatural killer cellsPortugal

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.0K
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

9.9K

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
110
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53